scholarly article | Q13442814 |
P50 | author | Rudolf Gesztelyi | Q42708671 |
Judit Remenyik | Q61472399 | ||
Zsolt Barta | Q79267706 | ||
Adam Kemeny-Beke | Q90473327 | ||
P2093 | author name string | Peter Szodoray | |
Judit Zsuga | |||
Aniko Rentka | |||
Eva Zold | |||
Attila Biro | |||
Levente Czompa | |||
P2860 | cites work | THE EXTRA-INTESTINAL COMPLICATIONS OF CROHNʼS DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTS | Q22242792 |
LASIK in patients with rheumatic diseases: a pilot study. | Q33223496 | ||
LASIK outcomes in patients with underlying systemic contraindications: a preliminary study | Q33241546 | ||
Ophthalmologic manifestations in patients with inflammatory bowel disease | Q33819519 | ||
A review of quality of life measures in dry eye questionnaires | Q34364536 | ||
Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes | Q34800055 | ||
The relationship between clinical signs and dry eye symptoms. | Q35208749 | ||
Outcomes and complications of excimer laser surgery in patients with collagen vascular and other immune-mediated inflammatory diseases | Q36231876 | ||
Challenges and pitfalls in clinical trials of treatments for dry eye. | Q36639883 | ||
Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease | Q37098461 | ||
Prevalence and characteristics of ophthalmological extra-intestinal manifestations in Chinese patients with inflammatory bowel disease | Q37359860 | ||
Minimal clinically important difference for the ocular surface disease index | Q37672025 | ||
Managing IBD outside the gut: ocular manifestations | Q38136957 | ||
Etiopathogenesis of inflammatory bowel disease: today and tomorrow. | Q38840349 | ||
Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases | Q38866963 | ||
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology | Q40390478 | ||
Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease | Q43226675 | ||
Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel disease | Q43998152 | ||
Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study | Q46483966 | ||
Mucins and ocular signs in symptomatic and asymptomatic contact lens wear | Q47314621 | ||
Clinical tests for successful contact lens wear: relationship and predictive potential | Q47314627 | ||
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. | Q47758448 | ||
Exercise and Inflammatory Bowel Disease: Insights into Etiopathogenesis and Modification of Clinical Course. | Q49656358 | ||
Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease. | Q50075113 | ||
Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. | Q50543867 | ||
Controlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease. | Q51741521 | ||
Ocular complications of inflammatory bowel disease | Q59121199 | ||
Primary, secondary and coincidental ocular complications of Crohn's disease | Q70790819 | ||
The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study | Q73792791 | ||
Reliability and validity of the Ocular Surface Disease Index | Q73801624 | ||
Prevalence of and risk factors for dry eye syndrome | Q74298539 | ||
Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot study | Q75221575 | ||
The prevalence of ocular involvement in patients with inflammatory bowel disease | Q79687158 | ||
Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial | Q80330602 | ||
Ocular manifestations of inflammatory bowel disease | Q88247623 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammatory bowel diseases | Q917447 |
eye disease | Q3041498 | ||
P304 | page(s) | 8310583 | |
P577 | publication date | 2019-01-08 | |
P1433 | published in | BioMed Research International | Q17509958 |
P1476 | title | Evaluation of Objective Signs and Subjective Symptoms of Dry Eye Disease in Patients with Inflammatory Bowel Disease | |
P478 | volume | 2019 |
Search more.